跳至主要内容
临床试验/EUCTR2005-005709-50-DE
EUCTR2005-005709-50-DE进行中(未招募)1 期

Extracorporal shock wave therapy for induction of therapeutic neovascularization and homing of bone marrow progenitor cells in patients with chronic ischemic heart disease - Cell-Wave-CHF

Cardiology, University of Frankfurt0 个研究点目标入组 100 人开始时间: 2006年1月9日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ·Patients with chronic ischemic cardiomyopathy
  • ·s/p anterior myocardial infarction > 3 months
  • ·18-80 years
  • ·Male or female
  • ·Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ·Myocardial infarction < 3 months
  • ·ventricular thrombus
  • ·acute infection or fever
  • ·chronic inflammatory diseases ( M. Crohn, Rheumatoid Arthritis)
  • ·HIV Infection or active Hepatitis
  • ·Neoplastic Diseases without complete remission in the last 5 years
  • ·Stroke within 3 months
  • ·renal insufficiency (Kreatinin > 2 mg/dl) before treatment
  • ·Liver disease (GOT > 2x upper limit, or spontaneous INR > 1,5).
  • ·Anemia (Hemoglobin < 10 mg/dl)
  • ·Platelets <100.000/µl
  • ·Known allergies to aspirin, clopidogrel or heparin
  • ·bleeding disorder
  • ·gastrointestinal bleeding within last 3 months
  • ·surgery or trauma < 2 months
  • ·mental retardation
  • ·Inclusion in other study within last 30 days

研究者

发起方
Cardiology, University of Frankfurt

相似试验

Extracorporal shock wave therapy for induction of... | 临床试验